期刊文献+

肺炎嗜衣原体CPAF原核表达载体的构建及其在大肠杆菌中的高效表达 被引量:1

Construction of Prokaryotic Vector Encoding Chlamydophila Pneumoniae CPAF and Its Effective Expression in E.coli
下载PDF
导出
摘要 目的对肺炎嗜衣原体蛋白酶样活性因子(CPAF)基因进行原核表达,为肺炎嗜衣原体的诊断及疫苗研究奠定基础。方法利用PCR技术从肺炎嗜衣原体标准株AR-39中扩增CPAF基因,将其克隆于原核表达载体pGEX-6p-2中,构建重组表达载体。并用双酶切、PCR及序列测定等方法进行鉴定后,在大肠杆菌中诱导表达GST融合蛋白。结果重组质粒中CPAF基因序列与肺炎嗜衣原体AR-39的同源性达到100%,CPAF在大肠杆菌中表达高效的GST融合蛋白。结论成功构建肺炎嗜衣原体CPAF基因的原核表达系统,并成功表达重组蛋白,为肺炎嗜衣原体疫苗的研究和临床检测试剂盒的研制打下基础。 Objective To express the recombinant protein of chlamydial protease-like activity factor CPAF from Chlamydophila pneumoniae for using in diagnosis and vaccine development. Methods The CPAF gene was amplified from the genome of C. pneumoniae strain AR-39,cloned into prokaryotic expression vector pGEX-6p-2 for fusion expression with GST. With identification by sequencing,the recombinant plasmid was transformed into Escherichia coli XL1-Blue and the recombinant proteins fused with GST was analyzed by SDS-PAGE. Results Sequence of the cloned CPAF gene was correct. The CPAF gene could be expressed in E. coli XL1-Blue which was transformed with pGEX-6p-2/CPAF but could not be expressed in E. coli XL1- Blue with pGEX-6p-2 or untransformed cells. Conclusion The Prokaryotic expression plasmid pGEX-6p-2/CPAF was successfully constructed and expressed in E. coli XL1-Blue,which is useful in C.pneumoniae diagnosis and vaccine development.
出处 《中南医学科学杂志》 CAS 2011年第6期615-618,共4页 Medical Science Journal of Central South China
基金 国家自然科学基金(30901352) 2008湖南省教育厅研究生科研创新基金
关键词 肺炎嗜衣原体 CPAF基因 原核表达 Chlamydophila pneumoniae CPAF gene prokaryotic expression
  • 相关文献

参考文献9

  • 1Dong F,,Zhong Y,Arulanandam B,et al.Production of a proteolytically active protein,chlamydial protease/protea-some-like activity factor,by five different Chlamydia spe-cies. Infection and Immunity . 2005
  • 2Sharma J,Bosnic AM,Piper JM,et al.Human antibody re-sponses to a Chlamydia-secreted protease factor. Infection and Immunity . 2004
  • 3Kuo C C,Jackson L A,Campbell L A,et al.Chlamydia pneumoniae (TWAR). Clinical Microbiology Reviews . 1995
  • 4Blasi F,Tarsia P,Aliberti S.Chlamydophila pneumoniae. Clinical Microbiology and Infection . 2009
  • 5Cosentini R,Tarsia P,Canetta C,et al.Severe asthma exacerbation:role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respiratory Research . 2008
  • 6Paldanius M,Bloigu A,Alho M,et al.Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland. Clinical and Diagnostic Laboratory Immunology . 2005
  • 7Shrama J,Dong F,Pirbhai M, et al.Inhibition of Proteolytic Activity of a Chlamydial Proteasome/Protease-like Activity factor by Antibodies from Humans Infected with Chlamydia Trachomatis. Infection and Immunity . 2005
  • 8Hammerschlag MR.Activity of gemifloxacin and other new quinolones against Chlamydia pneumoniae:a review. Journal of Antimicrobial Chemotherapy . 2000
  • 9Littman AJ,White E,Jackson LA,et al.Chlamydia pneumoniae Infection and Risk of Lung Cancer. Cancer Epidemiol. Biomarkers Prev . 2003

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部